Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder Cancer

التفاصيل البيبلوغرافية
العنوان: Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder Cancer
المؤلفون: Eure, Gregg R., Cundiff, Maria R., Schellhammer, Paul F.
المصدر: The Journal of Urology; February 1992, Vol. 147 Issue: 2 p376-379, 4p
مستخلص: Numerous studies have shown bacillus Calmette-Guerin (BCG) to be an effective prophylactic and therapeutic agent for superficial transitional cell carcinoma of the bladder. The high grade stage T1 lesion treated by transurethral resection alone is reported to progress to muscle invasion in 30 to 50% of the patients. Therefore, some have recommended treatment with cystectomy. To evaluate BCG treatment of the stage T1 lesion we reviewed our results with a single or repeated 6-week course of the Armand-Frappier Pasteur strain BCG and compared them with those in the literature. We also compared these results with those of treatment of the stage TA lesion.
قاعدة البيانات: Supplemental Index